Cost-effectiveness of secukinumab compared to other biologics in the treatment of ankylosing spondylitis in Finland

• Principais autores: Purmonen T (Autor), Puolakka K (Autor), Mishra D (Autor), Gunda P (Autor), Martikainen J (Autor)
• Formato: Livro
• Publicado em: Dove Medical Press, 2019-02-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Timo Purmonen,1 Kari Puolakka,2 Dinesh Mishra,3 Praveen Gunda,3 Janne Martikainen4 1Novartis Finland Oy, Espoo, Finland; 2South Karelia Central Hospital, Lappeenranta, Finland; 3Novartis Product Lifecycle Services-NBS, Novartis Healthcare Private Limited, Hyderabad, India; 4School of Pharmacy, Unive...